These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3214765)

  • 1. Statistical issues in the planning of prevention studies.
    Zelen M
    Cancer Invest; 1988; 6(5):615-20. PubMed ID: 3214765
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance and nature of cancer prevention trials.
    Byar DP; Freedman LS
    Semin Oncol; 1990 Aug; 17(4):413-24. PubMed ID: 2201087
    [No Abstract]   [Full Text] [Related]  

  • 3. Selection of participants for clinical trials in cancer prevention.
    Horton J
    Semin Oncol; 1983 Sep; 10(3):348-54. PubMed ID: 6665561
    [No Abstract]   [Full Text] [Related]  

  • 4. Methodologic issues in the design of primary prevention trials.
    Buring JE; Hennekens CH
    Prog Clin Biol Res; 1989; 293():41-9. PubMed ID: 2657774
    [No Abstract]   [Full Text] [Related]  

  • 5. Interpretation of cancer prevention trials.
    Moon TE
    Prev Med; 1989 Sep; 18(5):721-31. PubMed ID: 2694166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new design for randomized clinical trials.
    Zelen M
    N Engl J Med; 1979 May; 300(22):1242-5. PubMed ID: 431682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some statistical considerations for design of cancer prevention trials.
    Byar DP
    Prev Med; 1989 Sep; 18(5):688-99. PubMed ID: 2694163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size determination in clinical trials with time-dependent rates of losses and noncompliance.
    Lakatos E
    Control Clin Trials; 1986 Sep; 7(3):189-99. PubMed ID: 3802834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Special aspects of cancer prevention trials.
    Nixon DW
    Cancer; 1994 Nov; 74(9 Suppl):2683-6. PubMed ID: 7954286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current issues in cancer chemoprevention.
    Buring JE; Hennekens CH
    IARC Sci Publ; 1990; (103):185-93. PubMed ID: 2279796
    [No Abstract]   [Full Text] [Related]  

  • 11. The trials of prevention trials.
    Smigel K
    J Natl Cancer Inst; 1989 Aug; 81(15):1123-6. PubMed ID: 2746664
    [No Abstract]   [Full Text] [Related]  

  • 12. Are primary cancer prevention trials feasible?
    Zelen M
    J Natl Cancer Inst; 1988 Nov; 80(18):1442-4. PubMed ID: 3054126
    [No Abstract]   [Full Text] [Related]  

  • 13. Study design for the prevention of aerodigestive tract cancers.
    Moon TE
    Adv Exp Med Biol; 1992; 320():105-9. PubMed ID: 1442274
    [No Abstract]   [Full Text] [Related]  

  • 14. Statistical designs for investigating several interventions in the same study: methods for cancer prevention trials.
    Freedman LS; Green SB
    J Natl Cancer Inst; 1990 Jun; 82(11):910-4. PubMed ID: 2187999
    [No Abstract]   [Full Text] [Related]  

  • 15. Ready, set, go...stop: lessons learned from cancer prevention trials.
    Eastman P
    J Natl Cancer Inst; 1998 Apr; 90(7):494-6. PubMed ID: 9539243
    [No Abstract]   [Full Text] [Related]  

  • 16. Compliance issues in quality of life assessment: experiences of two Cancer Research Campaign sponsored groups.
    Fallowfield L
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):541-6. PubMed ID: 9549803
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamins E and C in the prevention of cardiovascular disease and cancer in men.
    Roberts LJ; Traber MG; Frei B
    Free Radic Biol Med; 2009 Jun; 46(11):1558. PubMed ID: 19285130
    [No Abstract]   [Full Text] [Related]  

  • 18. Planning the size of clinical trials with allowance for patient noncompliance.
    Moussa MA
    Methods Inf Med; 1990 Jul; 29(3):243-6. PubMed ID: 2215266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of serum and tissue pharmacology studies in the design and interpretation of chemoprevention trials.
    Plezia PM; Alberts DS; Peng YM; Xu MJ; Sayers S; Davis TP; Surwit EA; Meyskens FL
    Prev Med; 1989 Sep; 18(5):680-7. PubMed ID: 2694162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials of cancer prevention agents: true versus observed prevention effect.
    Moon TE
    Stat Med; 1986; 5(5):435-9. PubMed ID: 3786997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.